Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

54 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Role of recombinant interferon-gamma maintenance in responding patients with small cell lung cancer. A randomised phase III study of the EORTC Lung Cancer Cooperative Group.
van Zandwijk N, Groen HJ, Postmus PE, Burghouts JT, ten Velde GP, Ardizzoni A, Smith IE, Baas P, Sahmoud T, Kirkpatrick A, Dalesio O, Giaccone G. van Zandwijk N, et al. Among authors: burghouts jt. Eur J Cancer. 1997 Oct;33(11):1759-66. doi: 10.1016/s0959-8049(97)00174-3. Eur J Cancer. 1997. PMID: 9470829 Clinical Trial.
Two schedules of teniposide with or without cisplatin in advanced non-small-cell lung cancer: a randomized study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group.
Splinter TA, Sahmoud T, Festen J, van Zandwijk N, Sörenson S, Clerico M, Burghouts J, Dautzenberg B, Kho GS, Kirkpatrick A, Giaccone G. Splinter TA, et al. J Clin Oncol. 1996 Jan;14(1):127-34. doi: 10.1200/JCO.1996.14.1.127. J Clin Oncol. 1996. PMID: 8558187 Clinical Trial.
Randomized trial of alternating versus sequential radiotherapy/chemotherapy in limited-disease patients with small-cell lung cancer: a European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group Study.
Gregor A, Drings P, Burghouts J, Postmus PE, Morgan D, Sahmoud T, Kirkpatrick A, Dalesio O, Giaccone G. Gregor A, et al. J Clin Oncol. 1997 Aug;15(8):2840-9. doi: 10.1200/JCO.1997.15.8.2840. J Clin Oncol. 1997. PMID: 9256127 Clinical Trial.
Comparison of two carboplatin-containing regimens with standard chemotherapy for small cell lung cancer in a randomised phase II study. The EORTC Lung Cancer Cooperative group.
Postmus PE, Splinter TA, Palmen FM, Carney DN, Festen J, Burghouts JT, Vendrik C, Roozendaal K, Planting AS, Quoix E, et al. Postmus PE, et al. Among authors: burghouts jt. Eur J Cancer. 1992;28(1):96-100. doi: 10.1016/0959-8049(92)90394-h. Eur J Cancer. 1992. PMID: 1314632 Clinical Trial.
Economic evaluation of antibiotic prophylaxis in small-cell lung cancer patients receiving chemotherapy: an EORTC double-blind placebo-controlled phase III study (08923).
Tjan-Heijnen VC, Caleo S, Postmus PE, Ardizzoni A, Burghouts JT, Buccholz E, Biesma B, Gorlia T, Crott R, Giaccone G, Debruyne C, Manegold C; European Organisation for Research Treatment of Cancer-Lung Cancer Group and Health Economics Unit. Tjan-Heijnen VC, et al. Among authors: burghouts jt. Ann Oncol. 2003 Feb;14(2):248-57. doi: 10.1093/annonc/mdg073. Ann Oncol. 2003. PMID: 12562652 Free article. Clinical Trial.
Acute toxicity of alternating schedule of chemotherapy and irradiation in limited small-cell lung cancer in a pilot study (08877) of the EORTC Lung Cancer Cooperative Group.
Gregor A, Drings P, Rinaldi M, Schuster L, Burghouts J, Postmus PE, Dalesio O, Kirkpatrick A, Hoctin Boes G, Van Zandwijk N. Gregor A, et al. Ann Oncol. 1995 Apr;6(4):403-5. doi: 10.1093/oxfordjournals.annonc.a059193. Ann Oncol. 1995. PMID: 7619758 Free article. Clinical Trial. No abstract available.
54 results